Prime Therapeutics signs outcomes-based contract for Jardiance

Jardiance treats patients with type 2 diabetes and heart disease, lowering blood sugar and reducing the risk of death from heart disease.

from Most popular articles from Medical Marketing and Media http://ift.tt/2Fv2gbO